In Brief: Schering-Plough
This article was originally published in The Rose Sheet
Schering-Plough: Schering-Plough's two antifungal foot care brands -- Lotrimin AF and Tinactin -- helped the firm attain 50% market share in the athlete's foot market despite a 3.2% decline in the firm's overall foot care sales to $240 mil., according to the firm's recently released 1995 annual report. The company said it is launching Lotrimin AF Deodorant Powder spray and Tinactin Food and Sneaker Deodorant spray in early 1996. Schering-Plough's sun care business sales slid 1.6% to $127 mil. and revenues for the company's OTC segment declined 5.3% to $250 mil. for the year. The company's overall health care products revenues declined 3.6% to $632.7 mil. in 1995. The health care unit accounted for 12% of the company's consolidated sales of $5.1 bil. (up 12.5%) during the year. Schering-Plough net income declined 3.8% to $886.6 mil...
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review